mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.0008 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0009 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |